Department of Food Science and Human Nutrition, Iowa State University, Ames, IA, USA; Interdepartmental Microbiology Graduate Program, Iowa State University, Ames, IA, USA.
Department of Food Science and Human Nutrition, Iowa State University, Ames, IA, USA.
Poult Sci. 2020 Feb;99(2):752-762. doi: 10.1016/j.psj.2019.10.038. Epub 2019 Nov 28.
Commercial poultry farms are increasingly threatened by bacterial infections from avian pathogenic Escherichia coli (APEC) and broad-host Salmonella serovars. Recombinant attenuated Salmonella vaccines (RASV) elicit cross-reactive immune responses against APEC in chickens; however, assessment of broad protection is lacking. Probiotics boost chicken immunity and improve vaccination responses. The objective of this study was to determine whether the RASV, the probiotics, or their combination had protection against APEC and Salmonella. White Leghorn chicks were randomly placed into 4 groups: no treatment (CON), probiotics (PRO), RASV (VAX), or both prophylactics (P + V). Chicks in the PRO and P + V groups were fed probiotics daily, beginning at the age of 1-day-old. Chicks in the P + V and VAX groups were orally inoculated with RASV at the age of 4 D and boosted 2 wks later. Total and antigen-specific IgY responses to Salmonella (lipolysaccharide [LPS]) and E. coli (IroN and IutA) were measured in serum samples via ELISA. Bactericidal potential of both serum and blood against 42 APEC isolates comprising 25 serotypes was assessed in vitro. In vivo protection against APEC was evaluated by air sac challenge with APEC χ7122 (O78:K80), gross pathological lesions were scored, and bacterial loads were enumerated. In a second similar study, birds were orally challenged with S. Kentucky (CVM29188), and feces were enumerated for Salmonella at multiple time points. Vaccination elicited significant LPS-specific antibodies regardless of probiotics (P < 0.0001). Chicks in the P + V group demonstrated increased blood and serum bactericidal abilities against multiple APEC strains in vitro compared with the CON group. Following χ7122 challenge, P+V birds had less APEC in their blood (P < 0.001) and lower signs of airsacculitis (P < 0.01) and pericarditis/perihepatitis (P < 0.05) than CON birds. Finally, only P + V birds were negative for fecal Salmonella at all time points. This study shows this combination treatment may be a feasible method to reduce infection by APEC and Salmonella in chickens.
商业家禽养殖场越来越受到禽致病性大肠杆菌(APEC)和广谱沙门氏菌血清型的细菌感染的威胁。重组减毒沙门氏菌疫苗(RASV)在鸡中引发针对 APEC 的交叉反应性免疫应答;然而,缺乏对广泛保护的评估。益生菌可增强鸡的免疫力并改善疫苗接种反应。本研究旨在确定 RASV、益生菌或它们的组合是否对 APEC 和沙门氏菌具有保护作用。白来航鸡雏被随机分为 4 组:无处理(CON)、益生菌(PRO)、RASV(VAX)或两者预防性(P+V)。PRO 和 P+V 组的雏鸡从 1 日龄开始每天喂食益生菌。P+V 和 VAX 组的雏鸡在 4 日龄时口服接种 RASV,并在 2 周后加强免疫。通过 ELISA 测量血清样本中针对沙门氏菌(脂多糖 [LPS])和大肠杆菌(IroN 和 IutA)的总免疫球蛋白 Y(IgY)和抗原特异性 IgY 应答。在体外评估 42 株 APEC 分离株(包括 25 种血清型)对血清和血液的杀菌潜力。通过用 APEC χ7122(O78:K80)进行气囊挑战评估对 APEC 的体内保护作用,对大体病理病变进行评分,并对细菌负荷进行计数。在第二项类似的研究中,鸡通过口服攻毒 S. Kentucky(CVM29188),并在多个时间点对粪便进行沙门氏菌计数。无论是否使用益生菌,疫苗接种都能显著诱导 LPS 特异性抗体(P<0.0001)。与 CON 组相比,P+V 组的雏鸡在体外对多种 APEC 株的血液和血清杀菌能力有所提高。在 χ7122 攻毒后,与 CON 组相比,P+V 组的鸡血液中 APEC 减少(P<0.001),气囊炎(P<0.01)和心包炎/肝炎(P<0.05)的迹象也更少。最后,只有 P+V 组在所有时间点均未检测到粪便沙门氏菌。本研究表明,这种联合治疗方法可能是减少鸡中 APEC 和沙门氏菌感染的可行方法。